Related Experiment Video
Updated: Aug 7, 2026
06:21
Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
Multiple metabolic abnormalities in a patient with essential thrombocytosis
M Elisaf1, H Milionis, P Tomos
1Department of Internal Medicine, Medical School, University of Ioannina, 45110 Ioannina, Greece.
Platelets
|July 1, 1997
Abstract:
A patient with extreme essential thrombocytosis who exhibited an array of real or spurious metabolic abnormalities is described. Careful venipuncture and prompt measurement avoided unnecessary further laboratory investigation and potentially dangerous overtreatment.
Related Concept Videos
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...